NSG552 / NSG 552 EXAM 2: PSYCHOPHARMACOLOGY
PRACTICE QUESTIONS AND ANSWERS | WILKES
UNIVERSITY | 2026–2027
NSG 552 PSYCHOPHARMACOLOGY
COMPREHENSIVE PRACTICE EXAMINATION
Course: NSG 552 / NSG 552 Psychopharmacology
Institution: Wilkes University
Academic Year: 2026–2027
Document Type: Comprehensive Practice Examination
Questions: 100
Format: Multiple Choice and Short Answer
Includes: Answer Key and Detailed Rationales
Status: Original study/practice material — its an official university examination
TABLE OF CONTENTS
1. General Psychopharmacology Principles — Questions 1–10
2. Antidepressants — Questions 11–25
3. Antipsychotics — Questions 26–42
4. Mood Stabilizers — Questions 43–55
5. Anxiolytics and Sedative-Hypnotics — Questions 56–67
6. ADHD and Stimulant Pharmacotherapy — Questions 68–75
7. Substance Use and Addiction Pharmacotherapy — Questions 76–84
8. Dementia and Cognitive Disorders — Questions 85–90
9. Pediatric, Geriatric, and Special-Population Considerations — Questions
91–95
, 10. Medication Safety, Interactions, and Clinical Monitoring — Questions 96–
100
11. Comprehensive Answer Key
12. Detailed Rationales
SECTION I — GENERAL PSYCHOPHARMACOLOGY PRINCIPLES
Question 1 — Multiple Choice
Which statement best describes a pharmacokinetic process?
A. Serotonin binding to a postsynaptic receptor
B. Dopamine receptor blockade
C. Hepatic metabolism of a medication
D. GABA-A receptor activation
Correct Answer: C
Rationale: Pharmacokinetics describes what the body does to a medication, including
absorption, distribution, metabolism, and excretion. Hepatic metabolism is therefore
pharmacokinetic. Receptor binding and receptor activation are pharmacodynamic processes.
Question 2 — Multiple Choice
A medication has a long half-life. Which clinical implication is most appropriate?
A. It must always be administered intravenously.
B. It generally remains in the body longer after administration.
C. It is necessarily more potent than medications with shorter half-lives.
D. It cannot accumulate with repeated dosing.
Correct Answer: B
Rationale: Half-life is the time required for the plasma concentration of a medication to decrease
by approximately 50%. A longer half-life generally means the medication and/or its active
metabolites persist longer, potentially allowing less frequent dosing but also prolonging adverse
effects.
Question 3 — Short Answer
,What is the difference between a medication's therapeutic effect and its adverse effect?
Correct Answer: The therapeutic effect is the intended beneficial clinical effect, whereas an
adverse effect is an unwanted or potentially harmful effect occurring at therapeutic or other
clinically relevant doses.
Rationale: Psychopharmacologic medications frequently produce multiple physiologic effects.
The desired effect is the reason the medication is prescribed; adverse effects are unintended
effects that may affect tolerability, safety, adherence, or quality of life.
Question 4 — Multiple Choice
Which organ is primarily responsible for the metabolism of many psychotropic medications?
A. Heart
B. Liver
C. Pancreas
D. Spleen
Correct Answer: B
Rationale: The liver contains numerous metabolic enzymes, including cytochrome P450
enzymes, that metabolize many medications. Hepatic impairment can therefore alter medication
concentrations and increase the risk of adverse effects.
Question 5 — Multiple Choice
A patient taking several medications is at increased risk for a drug interaction. Which concept
refers specifically to one medication altering the absorption, metabolism, distribution, or
excretion of another?
A. Pharmacodynamic interaction
B. Pharmacokinetic interaction
C. Placebo effect
D. Therapeutic index
Correct Answer: B
Rationale: Pharmacokinetic interactions occur when one medication changes another
medication's concentration or exposure by affecting ADME processes. Pharmacodynamic
interactions occur when medications have additive, synergistic, or antagonistic effects at the
physiologic or receptor level.
, Question 6 — Short Answer
Why is medication adherence particularly important in the treatment of chronic psychiatric
disorders?
Correct Answer: Consistent adherence helps maintain therapeutic drug exposure, reduces
relapse risk, and allows clinicians to evaluate whether a medication is effective and tolerated.
Rationale: Psychiatric medications often require sustained treatment. Intermittent use may result
in inadequate symptom control, withdrawal or discontinuation symptoms with some medications,
and difficulty determining whether treatment is effective.
Question 7 — Multiple Choice
Which finding most strongly suggests a medication-related anticholinergic effect?
A. Excessive salivation
B. Diarrhea
C. Urinary retention
D. Bradycardia
Correct Answer: C
Rationale: Anticholinergic effects commonly include dry mouth, blurred vision, constipation,
urinary retention, tachycardia, and cognitive impairment. Urinary retention is therefore
characteristic.
Question 8 — Multiple Choice
Which neurotransmitter system is most directly associated with the mechanism of selective
serotonin reuptake inhibitors?
A. Serotonin
B. Acetylcholine
C. Histamine
D. Glutamate
Correct Answer: A
Rationale: SSRIs inhibit the serotonin transporter, reducing serotonin reuptake and increasing
serotonergic signaling in relevant neural pathways.
Question 9 — Short Answer
PRACTICE QUESTIONS AND ANSWERS | WILKES
UNIVERSITY | 2026–2027
NSG 552 PSYCHOPHARMACOLOGY
COMPREHENSIVE PRACTICE EXAMINATION
Course: NSG 552 / NSG 552 Psychopharmacology
Institution: Wilkes University
Academic Year: 2026–2027
Document Type: Comprehensive Practice Examination
Questions: 100
Format: Multiple Choice and Short Answer
Includes: Answer Key and Detailed Rationales
Status: Original study/practice material — its an official university examination
TABLE OF CONTENTS
1. General Psychopharmacology Principles — Questions 1–10
2. Antidepressants — Questions 11–25
3. Antipsychotics — Questions 26–42
4. Mood Stabilizers — Questions 43–55
5. Anxiolytics and Sedative-Hypnotics — Questions 56–67
6. ADHD and Stimulant Pharmacotherapy — Questions 68–75
7. Substance Use and Addiction Pharmacotherapy — Questions 76–84
8. Dementia and Cognitive Disorders — Questions 85–90
9. Pediatric, Geriatric, and Special-Population Considerations — Questions
91–95
, 10. Medication Safety, Interactions, and Clinical Monitoring — Questions 96–
100
11. Comprehensive Answer Key
12. Detailed Rationales
SECTION I — GENERAL PSYCHOPHARMACOLOGY PRINCIPLES
Question 1 — Multiple Choice
Which statement best describes a pharmacokinetic process?
A. Serotonin binding to a postsynaptic receptor
B. Dopamine receptor blockade
C. Hepatic metabolism of a medication
D. GABA-A receptor activation
Correct Answer: C
Rationale: Pharmacokinetics describes what the body does to a medication, including
absorption, distribution, metabolism, and excretion. Hepatic metabolism is therefore
pharmacokinetic. Receptor binding and receptor activation are pharmacodynamic processes.
Question 2 — Multiple Choice
A medication has a long half-life. Which clinical implication is most appropriate?
A. It must always be administered intravenously.
B. It generally remains in the body longer after administration.
C. It is necessarily more potent than medications with shorter half-lives.
D. It cannot accumulate with repeated dosing.
Correct Answer: B
Rationale: Half-life is the time required for the plasma concentration of a medication to decrease
by approximately 50%. A longer half-life generally means the medication and/or its active
metabolites persist longer, potentially allowing less frequent dosing but also prolonging adverse
effects.
Question 3 — Short Answer
,What is the difference between a medication's therapeutic effect and its adverse effect?
Correct Answer: The therapeutic effect is the intended beneficial clinical effect, whereas an
adverse effect is an unwanted or potentially harmful effect occurring at therapeutic or other
clinically relevant doses.
Rationale: Psychopharmacologic medications frequently produce multiple physiologic effects.
The desired effect is the reason the medication is prescribed; adverse effects are unintended
effects that may affect tolerability, safety, adherence, or quality of life.
Question 4 — Multiple Choice
Which organ is primarily responsible for the metabolism of many psychotropic medications?
A. Heart
B. Liver
C. Pancreas
D. Spleen
Correct Answer: B
Rationale: The liver contains numerous metabolic enzymes, including cytochrome P450
enzymes, that metabolize many medications. Hepatic impairment can therefore alter medication
concentrations and increase the risk of adverse effects.
Question 5 — Multiple Choice
A patient taking several medications is at increased risk for a drug interaction. Which concept
refers specifically to one medication altering the absorption, metabolism, distribution, or
excretion of another?
A. Pharmacodynamic interaction
B. Pharmacokinetic interaction
C. Placebo effect
D. Therapeutic index
Correct Answer: B
Rationale: Pharmacokinetic interactions occur when one medication changes another
medication's concentration or exposure by affecting ADME processes. Pharmacodynamic
interactions occur when medications have additive, synergistic, or antagonistic effects at the
physiologic or receptor level.
, Question 6 — Short Answer
Why is medication adherence particularly important in the treatment of chronic psychiatric
disorders?
Correct Answer: Consistent adherence helps maintain therapeutic drug exposure, reduces
relapse risk, and allows clinicians to evaluate whether a medication is effective and tolerated.
Rationale: Psychiatric medications often require sustained treatment. Intermittent use may result
in inadequate symptom control, withdrawal or discontinuation symptoms with some medications,
and difficulty determining whether treatment is effective.
Question 7 — Multiple Choice
Which finding most strongly suggests a medication-related anticholinergic effect?
A. Excessive salivation
B. Diarrhea
C. Urinary retention
D. Bradycardia
Correct Answer: C
Rationale: Anticholinergic effects commonly include dry mouth, blurred vision, constipation,
urinary retention, tachycardia, and cognitive impairment. Urinary retention is therefore
characteristic.
Question 8 — Multiple Choice
Which neurotransmitter system is most directly associated with the mechanism of selective
serotonin reuptake inhibitors?
A. Serotonin
B. Acetylcholine
C. Histamine
D. Glutamate
Correct Answer: A
Rationale: SSRIs inhibit the serotonin transporter, reducing serotonin reuptake and increasing
serotonergic signaling in relevant neural pathways.
Question 9 — Short Answer
